Dr. Kenneth H Yu, M.D.
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Pancreatic Cancer
Studies Gastroesophageal Junction Adenocarcinoma
8 reported clinical trials
21 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
BRCA1 positive
2Gastroesophageal Junction Adenocarcinoma
Stage IV
Stage III
BRCA1 positive
Affiliated Hospitals
Clinical Trials Kenneth H Yu, M.D. is currently running
ONC-392 + Pembrolizumab
for Non-Small Cell Lung Cancer
This trial tests ONC-392, an antibody that helps the immune system fight cancer, in patients with advanced or spreading tumors who haven't responded to other treatments. It works by blocking a protein that usually keeps immune responses in check, making it easier for the body to attack cancer cells.
Recruiting1 award Phase 1 & 212 criteria
Chemotherapy + Stem Cell Transplant
for Pancreatic Cancer
The clinical trial is a phase 1, single-arm trial that will evaluate the safety of the investigational treatment on metastatic cancer in patients who have a deleterious or suspected deleterious BRCA1, BRCA2, or PALB2 genetic alteration. The investigational treatment will involve 2 cycles of a combination of intravenous melphalan, BCNU, low-dose I.V. ethanol, vitamin B12b, and vitamin C in association with autologous hematopoietic stem cell infusion. A dose-escalation schedule will be employed for vitamin C.
Recruiting1 award Phase 115 criteria
More about Kenneth H Yu, M.D.
Clinical Trial Related7 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Kenneth H Yu, M.D. has experience with
- Autologous Hematopoietic Stem Cells
- BCNU
- Ethanol
- Melphalan
- Vitamin B12B
- Vitamin C
Breakdown of trials Kenneth H Yu, M.D. has run
Pancreatic Cancer
Gastroesophageal Junction Adenocarcinoma
Cancer
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kenneth H Yu, M.D. specialize in?
Kenneth H Yu, M.D. focuses on Pancreatic Cancer and Gastroesophageal Junction Adenocarcinoma. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Kenneth H Yu, M.D. currently recruiting for clinical trials?
Yes, Kenneth H Yu, M.D. is currently recruiting for 3 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Kenneth H Yu, M.D. has studied deeply?
Yes, Kenneth H Yu, M.D. has studied treatments such as Autologous Hematopoietic Stem Cells, BCNU, Ethanol.
What is the best way to schedule an appointment with Kenneth H Yu, M.D.?
Apply for one of the trials that Kenneth H Yu, M.D. is conducting.
What is the office address of Kenneth H Yu, M.D.?
The office of Kenneth H Yu, M.D. is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.